{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:26:25Z","timestamp":1790483185401,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["281035"],"award-info":[{"award-number":["281035"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jconrel.2018.07.045","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T02:44:42Z","timestamp":1533005082000},"page":"402-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin"],"prefix":"10.1016","volume":"286","author":[{"given":"Elena","family":"Presas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"McCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Nellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"V. Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Bazile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Brayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6915-6201","authenticated-orcid":false,"given":"Caitriona M.","family":"O'Driscoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jconrel.2018.07.045_bb0005","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1517\/17425247.2014.924500","article-title":"Orally active-targeted drug delivery systems for proteins and peptides","volume":"11","author":"Li","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"issue":"37","key":"10.1016\/j.jconrel.2018.07.045_bb0010","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","article-title":"Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.jconrel.2018.07.045_bb0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1089\/dia.2012.0038","article-title":"The role of comfort and discomfort in insulin therapy","volume":"14","author":"Aronson","year":"2012","journal-title":"Diabetes Technol. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2018.07.045_bb0020","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrd836","article-title":"New horizons [mdash] alternative routes for insulin therapy","volume":"1","author":"Owens","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.jconrel.2018.07.045_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.jconrel.2018.07.045_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.nano.2006.04.009","article-title":"Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems","volume":"2","author":"Pinto Reis","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2018.07.045_bb0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","article-title":"Lipid-based nanocarriers for oral peptide delivery","volume":"106","author":"Niu","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003088-200847010-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of insulin Glulisine","volume":"47","author":"Becker","year":"2008","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.jconrel.2018.07.045_bb0045","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1517\/17425240903222218","article-title":"Recent advances and future directions in amphiphilic cyclodextrin nanoparticles","volume":"6","author":"Bilensoy","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"issue":"25","key":"10.1016\/j.jconrel.2018.07.045_bb0050","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1039\/c2ob25490e","article-title":"A click chemistry route to 2-functionalised PEGylated and cationic [small beta]-cyclodextrins: co-formulation opportunities for siRNA delivery","volume":"10","author":"O'Mahony","year":"2012","journal-title":"Org. Biomol. Chem."},{"issue":"8","key":"10.1016\/j.jconrel.2018.07.045_bb0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2165\/00003495-200969080-00006","article-title":"Insulin Glulisine","volume":"69","author":"Garnock-Jones","year":"2009","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.jconrel.2018.07.045_bb0060","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/cn3000372","article-title":"Click-modified Cyclodextrins as nonviral vectors for neuronal siRNA delivery","volume":"3","author":"O'Mahony","year":"2012","journal-title":"ACS Chem. Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.07.045_bb0065","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2015.12.055","article-title":"A novel, anisamide-targeted cyclodextrin nanoformulation for siRNA delivery to prostate cancer cells expressing the sigma-1 receptor","volume":"499","author":"Fitzgerald","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2018.07.045_bb0070","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1038\/nprot.2006.202","article-title":"Using circular dichroism spectra to estimate protein secondary structure","volume":"1","author":"Greenfield","year":"2006","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0075","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/00032710600952432","article-title":"Polyacrylamide gel electrophoresis of insulin","volume":"40","author":"Chi","year":"2007","journal-title":"Anal. Lett."},{"issue":"Supplement C","key":"10.1016\/j.jconrel.2018.07.045_bb0080","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2017.02.024","article-title":"Rational design of polyarginine nanocapsules intended to help peptides overcoming intestinal barriers","volume":"263","author":"Niu","year":"2017","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2018.07.045_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2013.02.050","article-title":"Amphiphilic polyallylamine based polymeric micelles for siRNA delivery to the gastrointestinal tract: in vitro investigations","volume":"447","author":"Guo","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2018.07.045_bb0090","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/cbdd.12360","article-title":"Stability of bovine Lactoferrin in luminal extracts and mucosal homogenates from rat intestine: a prelude to oral absorption","volume":"84","author":"Yao","year":"2014","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jconrel.2018.07.045_bb0095","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1126\/science.1260419","article-title":"Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"issue":"33","key":"10.1016\/j.jconrel.2018.07.045_bb0100","doi-asserted-by":"crossref","first-page":"34380","DOI":"10.1074\/jbc.M403596200","article-title":"Insulin regulation of sterol regulatory element-binding Protein-1 expression in L-6 muscle cells and 3T3 L1 adipocytes","volume":"279","author":"Nadeau","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.jconrel.2018.07.045_bb0105","doi-asserted-by":"crossref","first-page":"29164","DOI":"10.1074\/jbc.273.44.29164","article-title":"Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors","volume":"273","author":"Boizard","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.jconrel.2018.07.045_bb0110","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1073\/pnas.97.15.8536","article-title":"Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets","volume":"97","author":"Kakuma","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2018.07.045_bb0115","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1074\/jbc.273.3.1349","article-title":"Sterol regulation of 3-Hydroxy-3-Methylglutaryl-coenzyme a synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor\/nuclear factor Y","volume":"273","author":"Dooley","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.jconrel.2018.07.045_bb0120","doi-asserted-by":"crossref","first-page":"18480","DOI":"10.1016\/S0021-9258(19)81383-2","article-title":"Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme a synthase","volume":"263","author":"Smith","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1523-1747.2000.00822.x","article-title":"Regulation of HMG-CoA synthase and HMG-CoA reductase by insulin and epidermal growth factor in HaCaT keratinocytes","volume":"114","author":"Harris","year":"2000","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2018.07.045_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/onc.2016.233","article-title":"Rewiring of the apoptotic TGF-\u03b2-SMAD\/NF\u03baB pathway through an oncogenic function of p27 in human papillary thyroid cancer","volume":"36","author":"Garcia-Rendueles","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2018.07.045_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejps.2015.09.001","article-title":"In vitro and in vivo preclinical evaluation of a minisphere emulsion-based formulation (SmPill\u00ae) of salmon calcitonin","volume":"79","author":"Aguirre","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.07.045_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2014.06.022","article-title":"In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin","volume":"189","author":"Nielsen","year":"2014","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2018.07.045_bb0145","doi-asserted-by":"crossref","DOI":"10.17795\/jjhr-36931","article-title":"Temperature and pH effects on insulin structure: a molecular dynamic approach","volume":"7","author":"Baheri","year":"2016","journal-title":"Jentashapir J. Health Res."},{"issue":"2","key":"10.1016\/j.jconrel.2018.07.045_bb0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.colsurfb.2006.09.012","article-title":"Development and characterization of new insulin containing polysaccharide nanoparticles","volume":"53","author":"Sarmento","year":"2006","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2018.07.045_bb0155","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3762\/bjnano.6.145","article-title":"Peptide-equipped tobacco mosaic virus templates for selective and controllable biomineral deposition","volume":"6","author":"Altintoprak","year":"2015","journal-title":"Beilstein J. Nanotechnol."},{"issue":"3","key":"10.1016\/j.jconrel.2018.07.045_bb0160","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2006.02.016","article-title":"Conjugates of poly(dl-lactic acid) with ethylenediamino or diethylenetriamino bridged bis(\u03b2-cyclodextrin)s and their nanoparticles as protein delivery systems","volume":"112","author":"Gao","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jconrel.2005.06.010","article-title":"Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono(6-(2-aminoethyl)amino-6-deoxy)-\u03b2-cyclodextrin and its properties as the new carrier of protein delivery system","volume":"107","author":"Gao","year":"2005","journal-title":"J. Control. Release"},{"issue":"18","key":"10.1016\/j.jconrel.2018.07.045_bb0170","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1039\/C4PY00278D","article-title":"Reverse micelles based on [small beta]-cyclodextrin-incorporated amphiphilic polyurethane copolymers for protein delivery","volume":"5","author":"Du","year":"2014","journal-title":"Polym. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2018.07.045_bb0175","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1039\/C4TB01351D","article-title":"Reverse micelles based on biocompatible [small beta]-cyclodextrin conjugated polyethylene glycol block polylactide for protein delivery","volume":"3","author":"Gu","year":"2015","journal-title":"J. Mater. Chem. B"},{"issue":"12","key":"10.1016\/j.jconrel.2018.07.045_bb0180","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1021\/acs.molpharmaceut.6b00561","article-title":"Dependence of intestinal absorption profile of insulin on carrier morphology composed of \u03b2-Cyclodextrin-grafted chitosan","volume":"13","author":"Daimon","year":"2016","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/mp400493b","article-title":"Penetratin derivative-based Nanocomplexes for enhanced intestinal insulin delivery","volume":"11","author":"Zhu","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2018.07.045_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.addr.2016.06.006","article-title":"Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs","volume":"106","author":"Griffin","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0195","first-page":"153","article-title":"Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin","volume":"327","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2018.07.045_bb0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejpb.2014.06.011","article-title":"Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs","volume":"88","author":"Fan","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"13","key":"10.1016\/j.jconrel.2018.07.045_bb0205","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1039\/c3ra47150k","article-title":"[small beta]-Cyclodextrin-conjugated amino poly(glycerol methacrylate)s for efficient insulin delivery","volume":"4","author":"Wang","year":"2014","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.jconrel.2018.07.045_bb0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jbm.a.30861","article-title":"Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system","volume":"80A","author":"Hui","year":"2007","journal-title":"J. Biomed. Mater. Res. A"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918304486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918304486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:41:58Z","timestamp":1759160518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918304486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"alternative-id":["S0168365918304486"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.07.045","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physicochemical, pharmacokinetic and pharmacodynamic analyses of amphiphilic cyclodextrin-based nanoparticles designed to enhance intestinal delivery of insulin","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.07.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}